Navigation Links
Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
Date:1/13/2009

Presentation Scheduled for Thursday, January 15th at 1:00PM PT

NEW YORK, Jan. 13 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, is scheduled to present at the J.P. Morgan 27th Annual Healthcare Conference being held in San Francisco.

Mr. Weiss' presentation will be webcast live on Thursday, January 15th at 1:00pm PT and will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company also has an in-licensin
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
3. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
4. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
7. Keryx Biopharmaceuticals Receives Nasdaq Notification
8. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
9. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
10. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
11. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Four of the top 10 pharma...rid eCTD submissions to Health Canada. Datafarm&rs...’s 7th Canadian DIA Annual Meeting where Hea...nsor companies may submit Hybrid eCTD regulatory s...ons with no prior permission request. , ...
(Date:11/8/2009)..., MOUNTAIN VIEW, Calif. Nov. 5, 2009 Compl...encing company, today announced publication of a r...rietary DNA sequencing platform, including analysi...es. The consumables cost for these three genomes s...oarrays ranged from $8,005 for 87x coverage to $1,...
(Date:11/6/2009)..., AURORA, Ontario, Nov. 6 /PRNewswire-FirstCall... Sheets: HXBPF) today announced that John Docherty...ent at Merriman Curhan Ford,s 6th annual Investor ...tel Hotel in New York City. Mr. Docherty will pro...development programs L-DOS47 and Topical Interfero...
(Date:11/6/2009)..., SPRING VALLEY, Calif., Nov. 6 ... awarded a Small Business Innovative Research (SBI...rch and Material command. Under terms of the agree...gents (ASRs) for the diagnosis of Dengue virus. ...that represents a major threat to military forces ...
Breaking Biology Technology:Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...inner of the Steven Burrill Technology Business P...heft product, and has an aggressive plan that call...ion customers after two years. , ,This probably so...at have multi-year plans to reach positive cash fl...credit card accounts - five to seven credit cards ...
...ed guilty in Milwaukee to charges of criminal copy...arly $6 million in counterfeit Rockwell Automatio...ney General Alice Fisher for the Criminal Division...n District of Wisconsin announced that Robert Kos...District Court Judge J.P. Stadtmueller, and Yutaka...
...ment of Energy will invest up to $375 million ove...rs, including $125 million for a center led by the... development of cellulosic ethanol. , ,The Madiso...ed the DOE Great Lakes Bioenergy Research Center, ... University and be directed by Timothy Donohue ,...
Other Biology Technology:Identity theft start up has fast-track growth plans 2Identity theft start up has fast-track growth plans 3Two convicted of selling $6 million in counterfeit Rockwell software on eBay 2UW-Madison to receive $125M for bioenergy research center 2UW-Madison to receive $125M for bioenergy research center 3
(Date:11/9/2009)...he hopeful news is that pediatric survival rates h...ewstreatments that enable survival often cause inf...e reached puberty currently have an opportunity to...r treatment, they may have their semen frozen and ...o not produce sperm, although their testicular tis...
(Date:11/9/2009)...t of Energy (DOE) has announced plans to fund rese...AB) School of Engineering on technologies that wou...e capture and permanent safe storage, or sequestra...ollaboration with Southern Company, the parent com...gh the 2009 American Recovery and Reinvestment Act...
(Date:11/9/2009)...ten is publishing a special issue "Beyond the Ori...rate Darwin,s On the Origin of Species which was p...tor and author of the lead article is Dr. Ulrich K...ionary biology at the University of Kassel in Germ...ble free of charge until 30 December 2009 on Sprin...
Breaking Biology News(10 mins):For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3New Vaccine from Intervet Schering Plough Animal Health is First for Canine Influenza Virus 49806 1New Vaccine from Intervet Schering Plough Animal Health is First for Canine Influenza Virus 49806 2New Vaccine from Intervet Schering Plough Animal Health is First for Canine Influenza Virus 49806 3New Vaccine from Intervet Schering Plough Animal Health is First for Canine Influenza Virus 49806 4Angelo Masciantonio CEO and Co Founder of HTH Worldwide Named Ernst 26 Young 2009 Entrepreneur Of The Year 28R 29 in Greater Philadelphia 49804 1Angelo Masciantonio CEO and Co Founder of HTH Worldwide Named Ernst 26 Young 2009 Entrepreneur Of The Year 28R 29 in Greater Philadelphia 49804 2Angelo Masciantonio CEO and Co Founder of HTH Worldwide Named Ernst 26 Young 2009 Entrepreneur Of The Year 28R 29 in Greater Philadelphia 49804 3Determining Who Will Respond to Brain Tumor Therapy 49802 1
...pting to predict the future impacts of climate cha...climate and ocean circulation. , In a November sp...cientists report that if current patterns of chang..., alterations of ocean circulation could occur on ...ions for the world,s climate and biosphere. , "Th...
...of native flora is in sourcing genetically diverse...ive vegetation to provide seed. , "A common belie...of seed for revegetation projects," says Dr Linda ...e agency. , "It has been presumed that local se... would provide the best results for restoration pr...
... a variety of hydrocarbon components of diesel fue...ocladium roseum (NRRL 50073), lives quietly withi...y Strobel of Montana State University has found th...ns, and that the particular diesel components prod...and environment of the fungus. The fungus even per...
Other Biology News:Ecologists use oceanographic data to predict future climate change 2Ecologists use oceanographic data to predict future climate change 3Obscure fungus produces diesel fuel components 2
HeLa Cell Slide from ProSci, Inc
EL4 Cell Slide from ProSci, Inc
IHC Select TE Buffer pH 9.0 [Antigen/ Epitope Retrieval Reagent], 10x from CHEMICON
Hep G2 Cell Slide from ProSci, Inc
Biology Products: